Enanta Pharmaceuticals Inc logo

Enanta Pharmaceuticals Inc

NEW
FRA:9EP (USA)  
€ 11.1 +0.30 (+2.78%) Aug 3
At Loss
P/B:
3.13
Market Cap:
€ 316.95M ($ 364.86M)
Enterprise V:
€ 223.89M ($ 257.73M)
Volume:
0
Avg Vol (2M):
152.00
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
152.00

Enanta Pharmaceuticals Inc (FRA:9EP) Dividend

Enanta Pharmaceuticals Inc (FRA:9EP) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -0.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:9EP Dividend

Does Enanta Pharmaceuticals Inc (FRA:9EP) pay a dividend?

Enanta Pharmaceuticals Inc (FRA:9EP) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Enanta Pharmaceuticals Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Enanta Pharmaceuticals Inc has returned capital to shareholders via buybacks at a rate of -0.9% over the past 3 years.

What are dividend-paying alternatives to Enanta Pharmaceuticals Inc?

For dividend-paying alternatives in Enanta Pharmaceuticals Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.